Food and Drug Administration (FDA) - November 6, 2003
The Food and Drug Administration ( FDA ) today informed CanaRx Services, Inc. (CanaRx), the business supplying prescription drugs to the City of Springfield, Mass., that its operations are illegal under federal law and that it continues to put American patients at risk by providing them with unapproved, illegal, and po
Food and Drug Administration (FDA) - November 6, 2003
This ruling sends a clear signal that those who would put profit before safety will not be allowed to threaten the public health. After reviewing the facts, Judge Eagan found that Rx Depot violates the law and that the safety, purity, and efficacy of drug products obtained through the defendants cannot be assured. Co
Food and Drug Administration (FDA) - November 5, 2003
FDA S Office of Women s Health Awards 5-Year Research Contracts The Food and Drug Administration s (FDA s) Office of Women s Health (OWH) today announced it has awarded contracts to seven academic institutions to conduct clinical research on women s health issues. The research conducted under these contracts is designe
Food and Drug Administration (FDA) - June 20, 2003
FDA Approves a Once Daily Protease Inhibitor for HIV Infection The Food and Drug Administration (FDA) today announced the approval of Reyataz (atazanavir sulfate), a protease inhibitor to be used in combination with other anti-retroviral agents for the treatment of patients with HIV infection. As with other anti-retr
Food and Drug Administration (FDA) - March 13, 2003
The Food and Drug Administration ( FDA ) today announced the accelerated approval of Fuzeon (enfuvirtide) for use in combination with other anti-HIV medications to treat advanced HIV-1 infection in adults and children ages 6 years and older. The accelerated approval of this new drug should provide new hope for those su
Food and Drug Administration (FDA) - March 12, 2003
Richard Klein, Office of Special Health Issues
As part of the Food and Drug Administration s ( FDA ) ongoing efforts to investigate and address unscrupulous counterfeiting activities, FDA s Office of Criminal Investigation has uncovered the existence of contaminated counterfeit Procrit, also known as epoetin alfa. Procrit is used to stimulate the production of red
Food and Drug Administration (FDA) - January 16, 2003
The Food and Drug Administration ( FDA ) today proposed new warnings for the labels of over-the-counter vaginal contraceptive drugs that contain the spermicide nonoxynol 9. The warning would state that vaginal contraceptives containing nonoxynol 9 do not protect against infection from HIV (human immunodeficiency virus,
This information is designed to support, not replace, the relationship that exists between you and your doctor.